Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2600115931) titled 'High-frequency deep brain stimulation of the subthalamic nucleus combined with low-frequency stimulation of the substantia nigra pars reticulata for the treatment of gait disorders in Parkinson's disease: a randomized, controlled, double-blind clinical trial' on Jan. 4.
Study Type: Interventional study
Study Design:
Cross-over
Primary Sponsor: Xuanwu Hospital, Capital Medical University
Condition:
Parkinson's Disease (Patients with Parkinson's Disease requiring deep brain stimulation)
Intervention:
Group1:The subject first receives conventional high-frequency stimulation of the subthalamic nucleus (STN) wi...